A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
2020-07-04
عنوان الدراسة
A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
داعم الدراسة
Alcon
دواء الدراسة
Travoprost 0.004% / Timolol
رقم بروتوكول الدراسة
C-12-008
حالة الدراسة
Completed
موقع الدراسة
King Khaled Eye Specialist Hospital (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.